Skip to main content
VCbacked
Log inGet Started

Sight Sciences

Menlo Park, United States

Sight Sciences is a medical device company that uses a computer-based device designed for the treatment of eye disease.

$35.0M raised
Jan 2024
Post-IPO Debt
EyewearHealth CareHealth Diagnostics

Top Investors

Hercules CapitalMidCap FinancialD1 Capital PartnersKCKScientific Health Development Partners

Founder Contacts

30,000+ verified contacts
Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Sight Sciences

How much funding has Sight Sciences raised?
Sight Sciences has raised $35.0M in total funding. The most recent round was Post-IPO Debt. The last funding was announced in January 2024.
Who are Sight Sciences's investors?
Sight Sciences's investors include Hercules Capital, MidCap Financial, D1 Capital Partners, KCK, Scientific Health Development Partners.
Where is Sight Sciences headquartered?
Sight Sciences is headquartered in Menlo Park, United States.
What does Sight Sciences do?
Sight Sciences is a medical device company that uses a computer-based device designed for the treatment of eye disease.
What stage is Sight Sciences at?
Sight Sciences is at the Post-IPO Debt stage.
Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Sight Sciences — Funding & Investors." VCBacked, January 23, 2024, https://www.vcbacked.co/company/sight-sciences. Accessed July 2, 2026.
APA
VCBacked. (2024). Sight Sciences — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/sight-sciences
Wikipedia (cite web)
{{cite web |title=Sight Sciences — Funding & Investors |url=https://www.vcbacked.co/company/sight-sciences |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated .

Similar Companies in Eyewear

View all
Bloobloom
London$4.0M
Pulsewave
Biel$120K
SiVIEW
Paris$5.5M
Alio Labs
Santa Rosa$3.0M
EyeQue
Newark$40.8M
ViXion
Tokyo$7.2M